GlassScriptPhysician profile
Asia Edusa
NPI 1225064587
$678.43
in general payments reported to CMS, 2019-2025
12 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $18.89 · 2023: $64.04 · 2024: $133 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $167.59 | 2019-2025 | Slynd |
| Abbvie INC. | $145.69 | 2019-2023 | Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $57.78 | 2019-2024 | |
| Astellas Pharma US INC | $55.33 | 2025 | Veozah |
| Mayne Pharma Commercial LLC | $51.78 | 2024-2025 | |
| Coopersurgical, INC. | $50.51 | 2019-2020 | |
| Allergan, INC. | $36.24 | 2019 | |
| Exact Sciences Corporation | $33.54 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $26.90 | 2025 | |
| Aspira Women'S Health INC | $19.89 | 2025 | Ova1 |
| Sage Therapeutics, LLC | $16.85 | 2024 | |
| Amag Pharmaceuticals, INC. | $16.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asia Edusa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.